FINWIRES · TerminalLIVE
FINWIRES

Sunshine Lake Pharma to Establish Investment Vehicle With Controlling Shareholder

By

Sunshine Lake Pharma (HKG:6887) is establishing a partnership fund to invest in companies operating in the healthcare, biomedicine, and artificial intelligence space, according to a Hong Kong bourse filing Friday.

The firm will establish Shenzhen Dongyangguang Houde Jianxing Venture Investment Fund Partnership with Shenzhen HEC Technology and Zhejiang HEC Health, its controlling shareholder, to invest in leading start-up projects as part of a broader strategy to expand its drug pipeline.

Sunshine Lake will contribute 500 million yuan to the fund for a 25% stake, with a further 1.5 billion yuan coming from Zhejiang HEC Health for 74.9% ownership.

Shenzhen HEC Technology will invest a nominal 2 million yuan for 0.1% of the fund and serve as the general partner of the investment vehicle.

Related Articles